Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR6 | P50406 | 2/20 | 0.42 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.39 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.39 |
| ▸ | IDO1 | P14902 | 2/20 | 0.38 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.38 |
| ▸ | BCHE | P06276 | 2/20 | 0.36 |
| ▸ | MAOA | P21397 | 3/20 | 0.36 |
| ▸ | MAOB | P27338 | 3/20 | 0.36 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.36 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.36 |
| ▸ | ACHE | P22303 | 1/20 | 0.36 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.36 |
| ▸ | SRD5A1 | P18405 | 1/20 | 0.35 |
| ▸ | DRD2 | P14416 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10447649 | 0.80 | HTR6 (0.47) | HTR6MTNR1AMTNR1BIDO1PDPK1 | |
| SCHEMBL18025388 | 0.77 | MTNR1A (0.48) | HTR6MTNR1AMTNR1BPDPK1BCHE | |
| SCHEMBL28768460 | 0.76 | HTR6 (0.50) | HTR6MTNR1AMTNR1BIDO1PDPK1 | |
| SCHEMBL22400816 | 0.74 | CA2 (0.54) | ADRA2BADRA2C | |
| SCHEMBL7680750 | 0.73 | HTR6 (0.42) | HTR6MTNR1AMTNR1BIDO1PDPK1 | |
| SCHEMBL7677975 | 0.73 | HTR6 (0.44) | HTR6MTNR1AMTNR1BIDO1PDPK1 | |
| SCHEMBL10447102 | 0.71 | IDO1 (0.46) | IDO1 | |
| SCHEMBL9115029 | 0.70 | HTR6 (0.54) | HTR6MTNR1AMTNR1BIDO1PDPK1 | |
| SCHEMBL14143008 | 0.70 | CA2 (0.45) | HTR6MTNR1AMTNR1BIDO1PDPK1 | |
| SCHEMBL6978852 | 0.70 | CA2 (0.45) | HTR6MTNR1AMTNR1BIDO1PDPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3458445-A1 | KRAS G12C INHIBITORS | Mirati Therapeutics, Inc. (US) | 2019-03-27 | — | — | EP | disclosed |
| WO-2017201161-A1 | KRAS G12C INHIBITORS | Mirati Therapeutics, Inc. (US) | 2017-11-23 | — | — | WO | disclosed |